Skin Infections | The Truth About Skin Care

{ Tag Archives } Skin Infections

Lytix Biopharma AS Announces Approval By Hungarian Authorities To Start Phase IIa Clinical Trial With LytixarTM In Gram Positive Skin Infections

Main Category: Dermatology
Also Included In: Clinical Trials / Drug Trials; Infectious Diseases / Bacteria / Viruses
Article Date: 01 Sep 2010 – 6:00 PDT

email to a friend printer friendly opinions
<!– rate article
The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa [...]

Also tagged Biopharma, Broad Spectrum, Clinical Trial, Clinical Trials, Cross Resistance, Drug Resistant Bacteria, Gram Positive Bacteria, Gunnar, Hungarian Authorities, Infectious Diseases, Mechanism Of Action, Novel Drug, Patient Group, Pharmaceutical Company, Phase Iia, Rate Article, Regulatory Authorities, Resistant Staphylococcus Aureus, Skin Bacteria

2010 09 01 Skin Care News Comments Off

Which Of These Three, Absolutely Free Confirmed Grownup Acne Breakouts Cures Are You Currently Overlooking?

As it pertains to basically choosing the best adult cystic acne solution below is what every single critical grownup actually need to comprehend. It may perhaps rather demoralizing struggling with trouble acne breakouts breakouts week right after week. The majority of adults looking for cystic acne cures that function nicely are stunned to find out [...]

Also tagged Acne, Acne Breakouts, Acne Cure, acne cures, Acne Solution, Adult Acne, Beauty, Clogged Pores, Complexion, Cystic Acne, Death Anxiety, End Result, Fracture, Frequent Cause, Genuine Life, Health, Inflammatory Response, Life And Death, Pimple, Pimples, Skin Tone, Zits

2010 08 29 Skin Care News Comments (0)

Which Of These Three, Absolutely Free Confirmed Grownup Acne Breakouts Cures Are You Currently Overlooking?

2010 08 23 Skin Care News Comments (0)

Acne Rosacea Cause And Treatment

What is rosacea?
One of the most common skin problems today is acne rosacea or the swelling and redness on the face. Because there are no lab tests to diagnose it, most people mistake rosacea with an acne breakout. The usual symptoms include the appearance of small blood vessels on the face, an enlarged nose, occurrence [...]

Also tagged Acne, Acne Remedy, Acne Rosacea Treatment, Acne Treatment, Antibiotics, Blood Vessels, Causes Of Acne, Doxycycline, Forehead, Inflammations, Lab Tests, Laser Treatments, Minocycline, Pustules, Skin Laser, Skin Problems, Thirties, Time Intervals, Tiny Mites, Topical Creams

2010 07 17 Skin Care News Comments (0)

Dermatologic Infections In Cancer Patients Treated With EGFRI Therapy

Patients who experience dermatologic toxic effects from epidermal growth factor receptor inhibitors (EGFRIs) have a high prevalence of skin and nail infections, according to a new study published online December 9 in the Journal of the National Cancer Institute…

Also tagged Cancer Patients, Cancer Therapy, Growth Factor Receptor, Journal Of The National Cancer Institute, Nail Infections, National Cancer Institute, Prevalence, Toxic Effects

2009 12 11 Skin Care News Comments Off

New Guidelines For Treating Complicated Skin And Soft Tissue Infections

New evidence-based recommendations developed by the Surgical Infection Society to guide physicians in the diagnosis and management of complicated skin and soft tissue infections have been published in Surgical Infections, a peer-reviewed journal published by Mary Ann Liebert, Inc. Surgical Infections is the Official Journal of the Surgical Infection Society (SIS) and SIS-Europe…

Also tagged Diagnosis, Europe, Mary Ann Liebert, New Evidence, Peer Reviewed Journal, Physicians, Sis, Soft Tissue Infections, Surgical Infections

2009 12 04 Skin Care News Comments Off

Regional Collaboration In Australia’s Northern Territory Reduces Skin Infections In Aboriginal Children

A community-based program aimed at reducing the burden of skin disease across remote communities in Australia’s Northern Territory has been successful according to a study published November 24 in the open-access journal PLoS Neglected Tropical Diseases.

Also tagged Aboriginal Children, Australia, Northern Territory, Open Access, Regional Collaboration, Skin Disease, Tropical Diseases

2009 11 29 Skin Care News Comments Off

Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces that its most advanced oral antibacterial NXL103 (flopristin/linopristin), has started a Phase II clinical trial in adults with acute bacterial skin and skin structure infections (ABSSSI).

Also tagged Adults, Antibacterial, Bacterial Infections, Clinical Trial, Discovery, Global Problem, Microbial Resistance, Novel Antibiotics, Oral, Pharmaceutical Company, Phase Ii, Skin And Skin, Skin Structure Infections

2009 11 07 Skin Care News Comments Off

Theravance And Astellas Announce FDA Approval Of VIBATIVTM (telavancin) For The Treatment Of Complicated Skin And Skin Structure Infections

Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved VIBATIV™ (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.

Also tagged Adult Patients, Astellas Pharma Us, Astellas Pharma Us Inc, Fda, Fda Approval, Fda Approved, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Gram Positive Bacteria, Mrsa, Nasdaq, Skin And Skin, Skin Structure Infections, Staphylococcus Aureus, Strains, Telavancin, Theravance Inc, Thrx

2009 09 14 Skin Care News Comments Off

NovaBay Launches Clinical Study For Non-Antibiotic Treatment Of Impetigo, One Of The Most Common Skin Infections

NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo. NovaBay’s partner in the impetigo trial [...]

Also tagged Amex, Antibiotic Treatment, Clinical Stage, Compounds, Fungal Infections, Galderma, Impetigo, Lead, Novabay, Nyse Amex, Partner, Pharmaceuticals Inc, Phase 2a, Prevention, Proof Of Concept, Stage Company

2009 09 11 Skin Care News Comments Off

The Truth About Skin Care

{ Tag Archives } Skin Infections

Lytix Biopharma AS Announces Approval By Hungarian Authorities To Start Phase IIa Clinical Trial With LytixarTM In Gram Positive Skin Infections

Which Of These Three, Absolutely Free Confirmed Grownup Acne Breakouts Cures Are You Currently Overlooking?

Which Of These Three, Absolutely Free Confirmed Grownup Acne Breakouts Cures Are You Currently Overlooking?

Acne Rosacea Cause And Treatment

Dermatologic Infections In Cancer Patients Treated With EGFRI Therapy

New Guidelines For Treating Complicated Skin And Soft Tissue Infections

Regional Collaboration In Australia’s Northern Territory Reduces Skin Infections In Aboriginal Children

Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

Theravance And Astellas Announce FDA Approval Of VIBATIVTM (telavancin) For The Treatment Of Complicated Skin And Skin Structure Infections

NovaBay Launches Clinical Study For Non-Antibiotic Treatment Of Impetigo, One Of The Most Common Skin Infections

Home

Recommendations

Free Ebook

Latest News

Site Features

Get a free ebook valued at $8.95 when you sign up for our free Skincare Tips newsletter. The book The Truth About Skincare: How To Have Younger Looking Skin sells every day for $8.95 at Bargain Books Web. It's yours at no cost by immediate download when you sign up right now. You can unsubscribe any time, and the book is yours to keep.
Name:
Email: